FrancophonIA/ELRC3.0 huggingface dataset:
English: P-gp substrates or weak inhibitors: No relevant interactions with atenolol, digoxin, amlodipine or cimetidine have been observed.
Slovenian: Substrati P-gp ali šibki zaviralci P-gp: Z atenololom, z digoksinom, z amlodipinom in s cimetidinom niso opažali pomembnega medsebojnega delovanja.
English: Riprazo HCT tablets contain two active substances, called aliskiren and hydrochlorothiazide.
Slovenian: Tablete Riprazo HCT vsebujejo dve zdravilni učinkovini, imenovani aliskiren in hidroklorotiazid.
English: General In the event of severe and persistent diarrhoea, Riprazo HCT therapy should be stopped.
Slovenian: Splošno V primeru hude ali persistentne driske je treba zdravljenje z zdravilom Riprazo HCT prekiniti.
English: Similar food effect was observed for Riprazo HCT as for the individual monotherapies.
Slovenian: Pri zdravilu Riprazo HCT so opažali podoben vpliv hrane kot pri posameznih monoterapijah.
English: Riprazo HCT has been shown to be effective as a once-a-day antihypertensive treatment in adult patients, regardless of gender, age, body mass index and ethnicity.
Slovenian: Pokazalo se je, da je zdravilo Riprazo HCT učinkovito antihipertenzivno zdravljenje za enkrat dnevno odmerjanje pri odraslih bolnikih ne glede na spol, starost, indeks telesne mase in etnično pripadnost.
English: If photosensitivity reaction occurs during treatment with Riprazo HCT, it is recommended to stop the treatment.
Slovenian: Če med zdravljenjem z zdravilom Riprazo HCT pride do fotosenzitivnostne reakcije, je priporočena prekinitev zdravljenja.
English: 98 film-coated tablets (2x49; perforated unit dose blister)
Slovenian: 98 filmsko obloženih tablet (2x49; perforirani pretisni omoti za
English: Therefore, caution should be exercised when aliskiren is administered with ketoconazole, verapamil or other moderate P-gp inhibitors (clarithromycin, telithromycin, erythromycin, amiodarone).
Slovenian: Zato je potrebna previdnost pri sočasni uporabi aliskirena s ketokonazolom, z verapamilom ali z drugimi zmernimi zaviralci P-gp (klaritromicinom, telitromicinom, eritromicinom, amiodaronom).
English: The rate and extent of absorption of Riprazo HCT are equivalent to the bioavailability of aliskiren and hydrochlorothiazide when administered as individual monotherapies.
Slovenian: Hitrost in obseg absorpcije zdravila Riprazo HCT ustrezata biološki uporabnosti aliskirena in hidroklorotizida pri uporabi posameznih monoterapij.
English: Aliskiren is a substance that belongs to a new group of medicines called renin inhibitors.
Slovenian: Aliskiren je učinkovina, ki sodi v novo skupino zdravil z imenom zaviralci renina.
English: Riprazo HCT is not recommended for use in children and adolescents below age 18 due to a lack of data on safety and efficacy (see section 5.2).
Slovenian: Zaradi pomanjkanja podatkov o varnosti in učinkovitosti uporaba zdravila Riprazo HCT pri otrocih in mladostnikih pod 18 let ni priporočljiva (glejte poglavje 5.2).
English: Riprazo HCT combines two antihypertensive compounds to control blood pressure in patients with essential hypertension: Aliskiren belongs to the class of direct renin inhibitors and hydrochlorothiazide to the class of thiazide diuretics.
Slovenian: Zdravilo Riprazo HCT združuje dve antihipertenzivni sestavini za uravnavanje krvnega tlaka pri bolnikih z esencialno hipertenzijo: aliskiren sodi v skupino neposrednih zaviralcev renina, hidroklorotiazid pa v skupino tiazidnih diuretikov.
English: Digoxine or other digitalis glycosides: Thiazide-induced hypokalaemia or hypomagnesaemia may occur as undesirable effects, favouring the onset of digitalis-induced cardiac arrhythmias.
Slovenian: Digoksin ali ostali digitalisovi glikozidi: Lahko pride do pojava s tiazidi inducirane hipokaliemije ali hipomagneziemije - neželenih učinkov, ki povečujeta verjetnost za nastop srčnih aritmij, ki jih povzroča digitalis.
English: Aliskiren Aliskiren is an orally active, non-peptide, potent and selective direct inhibitor of human renin.
Slovenian: Aliskiren je peroralno delujoč nepeptiden močan in selektiven neposreden zaviralec renina pri človeku.
English: It is not known whether aliskiren is excreted in human milk.
Slovenian: RiprazoNi znano, ali se aliskiren izloča v materino mleko pri človeku.
English: It is therefore recommended to monitor the effects when initiating and adjusting furosemide therapy to avoid possible underutilisation in clinical situations of volume overload.
Slovenian: Zato je pri uvedbi in prilagajanju zdravljenja s furosemidom pripročljivo spremljanje učinkov, da ne bi uporabljali premajhnih odmerkov v stanjih volumske preobremenitve.
English: Riprazo HCT should be used with caution in patients with heart failure due to limited clinical efficacy and safety data.
Slovenian: Pri bolnikih s popuščanjem srca je treba zaradi omejenega obsega podatkov o klinični učinkovitosti in varnosti zdravilo Riprazo HCT uporabljati previdno.
English: In controlled clinical trials, the incidence of diarrhoea in Riprazo HCT-treated patients was 1.3% compared to 1.4% for aliskirenor 1.9% for hydrochlorothiazide-treated patients.
Slovenian: V kontroliranih preskušanjih je bila incidenca driske pri uporabi zdravila Riprazo HCT 1,3 % v primerjavi z 1,4 % pri uporabi samo aliskirena oziroma z 1,9 % pri uporabi samo hidroklorotiazida.
English: Compounds that have been investigated in aliskiren clinical pharmacokinetic studies include acenocoumarol, atenolol, celecoxib, fenofibrate, pioglitazone, allopurinol, isosorbide-5-mononitrate, digoxin, metformin, amlodipine, atorvastatin, cimetidine and hydrochlorothiazide.
Slovenian: Med učinkovinami, ki so jih raziskovali v kliničnih farmakokinetičnih študijah aliskirena, so acenokumarol, atenolol, celekoksib, fenofibrat, pioglitazon, alopurinol, izosorbid-5-mononitrat, digoksin, metformin, amlodipin, atorvastatin, cimetidin in hidroklorotiazid.
English: Blood and lymphatic system disorders Rare:
Slovenian: Bolezni krvi in limfatičnega sistema redki: zelo redki:
English: P-glycoprotein interactions: MDR1/Mdr1a/1b (P-gp) was found to be the major efflux system involved in intestinal absorption and biliary excretion of aliskiren in preclinical studies.
Slovenian: Medsebojno delovanje s P-glikoproteinom: V predkliničnih študijah so ugotovili, da predstavlja MDR1/Mdr1a/1b (P-gp) najpomembnejši izlivni sistem pri absorpciji aliskirena v črevesju in njegovem izločanju z žolčem.
English: Following oral administration of Riprazo HCT tablets, the median peak plasma concentration time is within 1 hour for aliskiren and 2.5 hours for hydrochlorothiazide.
Slovenian: Po zaužitju tablet Riprazo HCT doseže aliskiren najvišjo koncentracijo v plazmi mediano v 1 uri, hidroklorotiazid pa v 2,5 urah.
English: Aortic and mitral valve stenosis, obstructive hypertrophic cardiomyopathy As with other vasodilators, special caution is indicated in patients suffering from aortic or mitral stenosis, or obstructive hypertrophic cardiomyopathy.
Slovenian: Stenoza aortne in mitralne zaklopke ter obstruktivna hipertrofična kardiomiopatija Tako kot pri uporabi drugih vazodilatatorjev je potrebna posebna previdnost pri bolnikih s stenozo aortne ali mitralne zaklopke ali z obstruktivno hipertrofično kardiomiopatijo.
English: • Allergic reactions (hypersensitivity) and angioedema (the symptoms of which can include difficulties in breathing or swallowing, rash, itching, hives or swelling of the face, hands and feet, eyes, lips and/or tongue, dizziness)
Slovenian: • alergijske reakcije (preobčutljivost) in angioedem (med njegovimi simptomi so lahko oteženo dihanje ali požiranje, izpuščaj, srbenje, koprivnica ali otekanje v obraz, roke in stopala, oči,
English: The adverse drug reactions previously reported with one of the individual components of Riprazo HCT (aliskiren and hydrochlorothiazide) and listed in the respective paragraphs on the individual components may occur with Riprazo HCT.
Slovenian: Neželeni učinki, o katerih so predhodno poročali pri uporabi ene od posameznih učinkovin zdravila Riprazo HCT (aliskiren in hidroklortiazid), so našteti v ustreznih odstavkih za posamezno učinkovino in se lahko pojavijo pri uporabi zdravila Riprazo HCT.
English: Therefore, because of the risk of therapeutic failure, grapefruit juice should not be taken together with Riprazo HCT.
Slovenian: Ker bi torej lahko prišlo do zmanjšanja terapevtskega učinka, se grenivkinega soka ne sme uživati skupaj z zdravilom Riprazo HCT.
English: Furosemide: When aliskiren was co-administered with furosemide, the AUC and Cmax of furosemide were reduced by 28% and 49%, respectively.
Slovenian: Furosemid: Pri sočasni uporabi aliskirena s furosemidom se je AUC furosemida znižala za 28 %, Cmax furosemida pa za 49 %.
English: Thiazides should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma.
Slovenian: Pri bolnikih z moteno funkcijo jeter ali s progresivno boleznijo jeter je treba tiazide uporabljati previdno, saj že pri majhnih spremembah ravnovesja tekočin in elektrolitov lahko pride do jetrne kome.
English: • Diarrhoea
Slovenian: • diareja,
English: In another clinical trial, the efficacy and safety of Riprazo HCT were also assessed in 489 obese hypertensive patients who did not respond to hydrochlorothiazide 25 mg (baseline systolic/diastolic blood pressure 149.4/96.8 mmHg).
Slovenian: V drugem kliničnem preskušanju so učinkovitost in varnost zdravila Riprazo HCT ocenjevali tudi pri 489 debelih hipertenzivnih bolnikih, ki se niso ustrezno odzvali na zdravljenje s 25 mg hidroklorotiazida (s sistoličnim/diastoličnim krvnim tlakom ob izhodišču 149,4/96,8 mmHg).
English: Riprazo HCT is contraindicated in patients with hypercalcaemia and should only be used after correction of any preexisting hypercalcaemia.
Slovenian: Zdravilo Riprazo HCT je kontraindicirano pri bolnikih s hiperkalciemijo in ga je mogoče uporabljati šele po korekciji morebitne že prisotne hiperkalciemije.
English: Information on Riprazo HCT interactions
Slovenian: Informacije o interakcijah zdravila Riprazo HCT
English: Grapefruit juice: Administration of grapefruit juice with aliskiren resulted in a decrease in AUC and Cmax of aliskiren.
Slovenian: Grenivkin sok: Uživanje grenivkinega soka z aliskirenom je zmanjšalo AUC in znižalo Cmax aliskirena.
English: Other inducers of P-gp (St. John's wort) might decrease the bioavailability of aliskiren.
Slovenian: Drugi induktorji P-gp (šentjanževka) bi lahko zmanjšali biološko uporabnost aliskirena.
English: Lithium: Renal clearance of lithium is reduced by thiazides, therefore the risk of lithium toxicity may be increased with hydrochlorothiazide.
Slovenian: Litij: Tiazidi zmanjšujejo ledvični očistek litija, zato zaradi hidroklorotiazida lahko pride do večjega tveganja za toksičnost litija.
English: As for other agents acting on the renin-angiotensin system, caution should be exercised when aliskiren is given in the presence of conditions pre-disposing to kidney dysfunction such as hypovolaemia (e.g. due to blood loss, severe or prolonged diarrhoea, prolonged vomiting, etc.), heart disease, liver disease, diabetes mellitus or kidney disease.
Slovenian: Kot pri uporabi drugih zdravil, ki delujejo na sistem renin-angiotenzin, je potreba previdnost pri uporabi aliskirena pri bolnikih z drugimi boleznimi, zaradi katerih so bolj nagnjeni k slabšemu delovanju ledvic, kot so hipovolemija (na primer zaradi izgube krvi, hude ali dolgotrajne diareje, dolgotrajnega bruhanja in podobno), bolezni srca, jeter, sladkorna bolezen ali bolezen ledvic.
English: P-gp potent inhibitors: A single dose drug interaction study in healthy subjects has shown that ciclosporin (200 and 600 mg) increases Cmax of aliskiren 75 mg approximately 2.5-fold and AUC approximately 5-fold.
Slovenian: Močni zaviralci P-gp: V študiji medsebojnega delovanja zdravil z enkratnim odmerjanjem pri zdravih osebah se je pokazalo, da ciklosporin (200 in 600 mg) zviša Cmax aliskirena (75 mg) približno 2,5-krat, AUC pa približno 5-krat.
English: Iodine contrasting agents: In case of diuretic-induced dehydration, there is an increased risk of acute renal failure, especially with high doses of iodine products.
Slovenian: Jodirana kontrastna sredstva: Pri bolnikih, ki so zaradi jemanja diuretikov dehidrirani, obstaja povečano tveganje za akutno odpoved ledvic, posebno pri uporabi visokih odmerkov jodiranih kontrastnih sredstev.
English: If you forget to take Riprazo HCT
Slovenian: Če ste pozabili vzeti zdravilo Riprazo HCT
English: Vitamin D and calcium salts: Administration of thiazide diuretics, including hydrochlorothiazide, with vitamin D or with calcium salts may potentiate the rise in serum calcium.
Slovenian: Vitamin D in kalcijeve soli: Sočasna uporaba tiazidnih diuretikov, vključno s hidroklorotiazidom, in vitamina D ali kalcijevih soli lahko stopnjuje zviševanje koncentracije kalcija v serumu.
English: No information is available on the treatment of overdose with Riprazo HCT.
Slovenian: O zdravljenju prevelikega odmerjanja zdravila Riprazo HCT ni na voljo nobenih podatkov.
English: For convenience, patients receiving aliskiren and hydrochlorothiazide from separate tablets may be switched to a fixed combination tablet of Riprazo HCT containing the same component doses.
Slovenian: Bolniki, ki jemljejo aliskiren in hidroklorotiazid v ločenih tabletah, lahko zaradi prikladnosti preidejo na uporabo že pripravljene kombinacije zdravila Riprazo HCT, ki vsebuje enake odmerke sestavin.
English: Additional information on individual components Other adverse reactions previously reported with one of the individual components may occur with Riprazo HCT even if not observed in clinical trials.
Slovenian: Pri uporabi zdravila Riprazo HCT lahko pride do drugih neželenih učinkov, ki so jih prej opisali pri uporabi katere od posameznih sestavin, tudi če jih v kliničnih preskušanjih niso opažali.
English: Treatment with Aliskiren up to 300 mg resulted in an overall incidence of adverse reactions similar to placebo.
Slovenian: Pri zdravljenju z aliskirenom v odmerkih do 300 mg je bila incidenca vseh neželenih učinkov skupaj podobna kot pri placebu.
English: Aliskiren was devoid of any mutagenic potential, embryo-foetal toxicity or teratogenicity.
Slovenian: Aliskiren ni izražal niti mutagenega potenciala niti znakov toksičnosti za zarodek oziroma plod ali teratogenosti.
English: As a result no dose adjustment for aliskiren or these coadministered medicinal products is necessary.
Slovenian: Zato ni treba prilagajati odmerkov aliskirena oziroma navedenih sočasno uporabljanih zdravil.
English: In hypertensive patients, once-daily administration of Riprazo HCT provided dose-dependent reductions in both systolic and diastolic blood pressure that were maintained over the entire 24-hour dose interval.
Slovenian: Pri hipertenzivnih bolnikih je jemanje zdravila Riprazo HCT enkrat dnevno omogočilo od odmerka odvisno znižanje tako sistoličnega kot diastoličnega krvnega tlaka in znižanje ohranilo ves čas 24urnega odmernega intervala.
English: 7 film-coated tablets 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 50 film-coated tablets 56 film-coated tablets 90 film-coated tablets 98 film-coated tablets
Slovenian: 7 filmsko obloženih tablet 14 filmsko obloženih tablet 28 filmsko obloženih tablet 30 filmsko obloženih tablet 50 filmsko obloženih tablet 56 filmsko obloženih tablet 90 filmsko obloženih tablet 98 filmsko obloženih tablet
English: Multi-packs (perforated unit dose blister) containing 98 x 1 tablets.
Slovenian: Skupna pakiranja (perforirani pretisni omoti za posamične odmerke) vsebujejo 98 x 1 tableto.
English: In sodium-depleted and/or volume-depleted patients, such as those receiving high doses of diuretics, symptomatic hypotension may occur after initiation of treatment with Riprazo HCT.
Slovenian: Bolniki s primanjkljajem natrija in/ali volumna telesnih tekočin Pri bolnikih s primanjkljajem natrija in/ali hipovolemijo, na primer pri bolnikih, ki prejemajo visoke odmerke diuretikov, se lahko po uvedbi zdravljenja z zdravilom Riprazo HCT pojavi simptomatska hipotenzija.
English: Non-depolarising skeletal muscle relaxants: Thiazides, including hydrochlorothiazide, potentiate the action of skeletal muscle relaxants such as curare derivatives.
Slovenian: Nedepolarizacijski relaksanti skeletnih mišic: Tiazidi, vključno s hidroklorotiazidom, lahko povečajo učinek relaksantov skeletnih mišic, kot so derivati kurara.
English: Riprazo HCT is available in packs containing 7, 14, 28, 30, 50, 56, 90,or 98 tablets.
Slovenian: Zdravilo Riprazo HCT je na voljo v pakiranjih po 7, 14, 28, 30, 50, 56, 90 ali 98 tablet.
English: If Riprazo HCT is used during breast-feeding, doses should be kept as low as possible.
Slovenian: Če bolnica uporablja zdravilo Riprazo HCT v času dojenja, naj uporablja čim nižje odmerke.
English: Co-administration with aliskiren 150 mg resulted in a 61% decrease in aliskiren AUC and co-administration with aliskiren 300 mg resulted in a 38% decrease in aliskiren AUC.
Slovenian: Sočasna uporaba z aliskirenom v odmerku 150 mg je zmanjšala AUC aliskirena za 61 %, sočasna uporaba z aliskirenom v odmerku 300 mg pa je zmanjšala AUC aliskirena za 38 %.
English: The known aliskiren adverse drug reactions are presented in the table below using the same convention as described previously for the fixed combination.
Slovenian: V spodnji preglednici so prikazani znani neželeni učinki aliskirena po enakem dogovoru, kot je zgoraj opisan za že pripravljeno kombinacijo zdravila.
English: Antidiabetic agents (e.g. insulin and oral antidiabetic agents): Thiazides may alter glucose tolerance.
Slovenian: Antidiabetična zdravila (npr. insulin in peroralni antidiabetiki): Tiazidi lahko vplivajo na toleranco za glukozo.
English: Single-packs containing 7, 14, 28, 30, 50 or 56 tablets.
Slovenian: Posamična pakiranja vsebujejo po 7, 14, 28, 30, 50 ali 56 tablet.
English: If hypokalaemia develops during hydrochlorothiazide therapy Riprazo HCT should be discontinued until stable correction of the potassium balance.
Slovenian: Če se hipokaliemija pojavi v času zdravljenja s hidroklorotiazidom, je treba uporabo zdravila Riprazo HCT prekiniti, dokler ni ravnovesje kalija stabilno.
English: Riprazo HCT was studied in a placebo-controlled trial including 2,762 hypertensive patients with diastolic blood pressure ≥ 95 mmHg and < 110 mmHg (mean baseline blood pressure of 153.6/99.2 mmHg).
Slovenian: Zdravilo Riprazo HCT so proučevali v preskušanju, kontroliranem s placebom; v katerem je bilo vključenih 2.762 hipertenzivnih bolnikov z diastoličnim krvnim tlakom ≥ 95 mmHg in < 110 mmHg (povprečna izhodiščna vrednost krvnega tlaka je bila 153,6/99,2 mmHg).
English: • Increased level of creatinine in the blood.
Slovenian: • zvišana raven kreatinina v krvi.
English: However, when driving vehicles or operating machinery it must be borne in mind that dizziness or drowsiness may occasionally occur when taking antihypertensive therapy.
Slovenian: Vendar pa je treba upoštevati, da lahko med jemanjem antihipertenzivnih zdravil občasno pride do omotičnosti ali dremavosti.
English: Aliskiren/hydrochlorothiazide combination
Slovenian: Kombinacija aliskiren/hidroklorotiazid
English: Riprazo HCT is indicated in patients whose blood pressure is not adequately controlled on aliskiren or hydrochlorothiazide used alone.
Slovenian: Zdravilo Riprazo HCT je indicirano za bolnike, katerih krvni tlak ni ustrezno urejen, če uporabljajo samo aliskiren ali samo hidroklorotiazid.
English: Serum potassium: In a large placebo-controlled clinical trial, the opposite effects of aliskiren (150 mg or 300 mg) and hydrochlorothiazide (12.5 mg or 25 mg) on serum potassium approximately balanced each other in many patients.
Slovenian: Kalij v serumu: V velikih kliničnih preskušanjih, kontroliranih s placebom, sta bila nasprotujoča si učinka aliskirena (150 mg ali 300 mg) in hidroklorotiazida (12,5 mg ali 25 mg) na kalij v serumu približno v ravnovesju pri mnogih bolnikih, pri drugih pa lahko prevlada en od obeh učinkov.
English: Riprazo HCT 150 mg/12.5 mg film-coated tablets Riprazo HCT 150 mg/25 mg film-coated tablets Riprazo HCT 300 mg/12.5 mg film-coated tablets Riprazo HCT 300 mg/25 mg film-coated tablets Aliskiren/hydrochlorothiazide
Slovenian: Riprazo HCT 150 mg/12,5 mg filmsko obloţene tablete Riprazo HCT 150 mg/25 mg filmsko obloţene tablete Riprazo HCT 300 mg/12,5 mg filmsko obloţene tablete Riprazo HCT 300 mg/25 mg filmsko obloţene tablete aliskiren/hiroklorotiazid
English: Anticholinergic agents and other medicinal products affecting gastric motility: The bioavailability of thiazide-type diuretics may be increased by anticholinergic agents (e.g. atropine, biperiden), apparently due to a decrease in gastrointestinal motility and the stomach emptying rate.
Slovenian: Antiholinergične zdravilne učinkovine in druga zdravila, ki vplivajo na motiliteto želodca: Antiholinergične zdravilne učinkovine (na primer atropin, biperiden) lahko povečajo biološko uporabnost diuretikov tiazidnega tipa, verjetno zaradi zmanjšanja motilitete prebavil in hitrosti praznjenja želodca.
English: Single-packs (perforated unit dose blister) containing 56 x 1 tablets.
Slovenian: Posamična pakiranja (perforirani pretisni omoti za posamične odmerke) vsebujejo 56 x 1 tableto.
English: In this difficult-to-treat population, Riprazo HCT provided a blood pressure reduction (systolic/diastolic) of 15.8/11.9 mmHg compared to 15.4/11.3 mmHg for irbesartan/hydrochlorothiazide, 13.6/10.3 mmHg for amlodipine/hydrochlorothiazide and 8.6/7.9 mmHg for hydrochlorothiazide monotherapy, with similar safety to hydrochlorothiazide monotherapy.
Slovenian: V tej populaciji, katere zdravljenje je zelo zahtevno, je zdravilo Riprazo HCT znižalo krvni tlak (sistolični/diastolični) za 15,8/11,9 mmHg v primerjavi z znižanjem za 15,4/11,3 mmHg pri uporabi irbesartana/hidroklorotiazida, za 13,6/10,3 mmHg pri uporabi amlodipina/hidroklorotiazida in za 8,6/7,9 mmHg pri uporabi hidroklorotiazida v monoterapiji, pri čemer je bila varnost zdravila Riprazo HCT podobna kot pri uporabi hidroklorotiazida v monoterapiji.
English: Excipients: Each tablet contains 50 mg lactose monohydrate and 49 mg wheat starch.
Slovenian: Pomožne snovi: Ena tabeta vsebuje 50 mg laktoze monohidrata in 49 mg pšeničnega škroba.
English: Moderate P-gp inhibitors: Co-administration of ketoconazole (200 mg) or verapamil (240 mg) with aliskiren (300 mg) resulted in a 76% or 97% increase in aliskiren AUC, respectively.
Slovenian: Zmerni zaviralci P-gp: Sočasna uporaba ketokonazola (200 mg) ali verapamila (240 mg) in aliskirena (300 mg) je povzročila zvečanje AUC aliskirena za 76 % oziroma 97 %.
English: Cytotoxic agents: Thiazides, including hydrochlorothiazide, may reduce the renal excretion of cytotoxic agents (e.g. cyclophosphamide, methotrexate) and potentiate their myelosuppressive effects.
Slovenian: Citotoksične zdravilne učinkovine: Tiazidi, vključno s hidroklorotiazidom, lahko zmanjšajo izločanje citotoksičnih zdravilnih učinkovin (npr. ciklofosfamida in metotreksata) preko ledvic in stopnjujejo njihov mielosupresiven učinek.
English: Hydrochlorothiazide:
Slovenian: Hidroklorotiazid:
English: In case severe or rapid hyponatraemia develops during Riprazo HCT therapy, the treatment should be discontinued until normalisation of natraemia.
Slovenian: Če se v času zdravljenja z zdravilom Riprazo HCT razvije huda ali nenadna hiponatriemija, je treba zdravljenje prekiniti do normalizacije vrednosti natrija v krvi.
English: Excipients: Each tablet contains 25 mg lactose monohydrate and 24.5 mg wheat starch.
Slovenian: Pomožne snovi: Ena tabeta vsebuje 25 mg laktoze monohidrata in 24,5 mg pšeničnega škroba.
English: When Riprazo HCT is used in patients with renal impairment, periodic monitoring of serum electrolytes including potassium, creatinine and uric acid serum levels is recommended.
Slovenian: Pri bolnikih z okvaro ledvic, ki jemljejo zdravilo Riprazo HCT, je priporočljivo periodično kontrolirati koncentracije elektrolitov v serumu, vključno s koncentracijami kalija, kreatinina in sečne kisline.
English: Riprazo HCT contains wheat starch.
Slovenian: Zdravilo Riprazo HCT vsebuje pšenični škrob.